Benefits
- May help ease occasional upset stomach
- Provides beneficial bacteria to help maintain optimal bacterial balance
- Provides enzymes and good bacteria that promote the absorption of nutrients
- Supports digestive health
- Helps to support immune health
- May support digestive comfort
- Supports bowel health
- Supports the metabolism of food for better nutrition
- A 10% savings!

Details
Isotonix® Digestive Enzyme Powder Drink is an isotonic-capable supplement designed to replenish essential digestive enzymes, contributing to good digestive health.
Ingredients
Ultimate Aloe Juice:
Aloe Vera Leaf
Ultimate Aloe is made from aloe vera leaf which undergoes a unique manufacturing process that carefully removes aloin and aloe-emodin while still maintaining high levels of polysaccharides. The polysaccharides in aloe have been shown to provide many health benefits. The International Aloe Science Council has certified the aloe content and purity in this product. Aloe vera contains vitamins, minerals, triglycerides, carbohydrates, amino acids, enzymes and water. The vitamins found in aloe include B1, B2, B3 and B12, choline, folic acid, vitamin C and beta-carotene (a precursor to Vitamin A), which are all vital to optimal health and the formation of certain key enzymes. Aloe has been shown to contain many beneficial minerals needed for good nutrition. Minerals found in aloe include calcium, magnesium, potassium, chloride, iron, zinc, manganese, copper, chromium, sulfur, boron, silicon, phosphorus, and sodium. These minerals are vital in the growth process and essential for the function of all body systems. Aloe vera also contains necessary triglycerides including fats, oil and waxes. These carry the fat-soluble vitamins and supply the fatty acids essential for growth and general health of the body. Aloe vera contains 20 of the 22 amino acids needed for good nutrition; nine of these are essential and must be supplied from an outside source because the body cannot manufacture its own. Aloe has been shown to contain all of the essential nine amino acids. Aloe vera also contains critical enzymes that trigger the chemical reaction of vitamins, minerals and hormones for normal functioning of the body.
Probiotics 10:
Clinical research has shown that probiotics support bowel health and much more. Probiotics help maintain a healthy balance of bacteria in the gastrointestinal tract and are increasingly important in the diet as we continue to rely on processed foods. Probiotics help to counter the negative effects that processed foods and numerous other factors may have on the bacterial balance in the gastrointestinal tract.
Lactobacillus plantarum
L. plantarum has been shown to promote optimal digestive health. L. plantarum competes for nutrients which the unhealthy bacteria live on. It is able to help reduce unhealthy bacteria (naturally present in the body) while preserving vital nutrients, antioxidants and vitamins. One of the talents of L. plantarum is its ability to synthesize L-lysine, an essential amino acid which is required for countless functions in the body.
Lactobacillus acidophilus
L. acidophilus is one of the most highly studied and widely used probiotic organisms. It is a strain of lactic acid producing, rod-shaped microbes that have numerous benefits for bowel health. L. acidophilus produces vitamin K, lactase, and anti-microbial substances such as acidolin, acidophilin, lactocidin, and bacteriocin. Due to the multiple functions of this microorganism, scientists have discovered that administering L. acidophilus orally helps maintain the proper balance within the digestive tract. L. acidophilus has been shown to support bowel health. The lactase that L. acidophilus creates is an enzyme that assists in the breakdown of lactose into simple sugars, which can support lactose metabolism.
Lactobacillus rhamnosus
L. rhamnosus is a strain of probiotics that aids in balancing the gastrointestinal microflora. It is one of the most intensely studied bacteria in the gastrointestinal tract. One of the remarkable things about L. rhamnosus is its ability to tolerate and even thrive in the harsh acidic conditions normally found in the stomach. Research has shown that L. rhamnosus helps maintain the integrity of the stomach lining.
Lactobacillus salivarius
L. salivarius resides in the mouth and small intestine. It has been shown to be effective in helping to reduce at least five potentially unhealthy bacteria in the mouth that are involved in producing dental plaque. L. salivarius appears to support homeostasis within the intestines.
Lactobacillus casei
L. casei is a rod-shaped species of Lactobacillus found in milk, cheese and dairy. It is a lactic acid producer like other species within the Lactobacillus genus and has been found to assist in the colonization of beneficial bacteria and can help relieve occasional diarrhea. L. casei is active in a broad temperature and pH range. It can be found naturally in the mouth and intestine of humans. It is a lactase producer which aids in healthy lactose metabolism and promoting bowel health.
Lactobacillus helveticus
L. helveticus has been well studied for many years and is commonly used in the production of Swiss-type cheeses to enhance flavor. Several beneficial probiotic effects are reported such as the ability to survive in the stomach and to reach the intestine alive, helping to support optimal lactose metabolism and helping to minimize the duration of occasional diarrhea. A number of studies have been conducted in regard to the myriad of potential health benefits offered by L. helveticus.
Bfidobacterium bifidum
Bifidobacterium are rod-shaped microbes that have been identified as the most important organisms in the intestine for providing barrier protection. Like Lactobacillus, Bifidobacterium are lactic acid producing microbes found in fermented foods such as yogurt and cheese. Despite the fact that when we are born Bifidobacterium makes up approximately 95% of the total gut population, the Bifidobacterium population decreases in our intestines as adults and then declines further as we advance in age. B. bifidum is the predominant bacteria strain found in the microflora of breast-fed infants. It is believed that B. bifidum contributes to the bowel health of breast-fed infants.
Bifidobacterium longum
B. longum is a branched, rod-shaped bacterium that competes with other bacteria for attachment sites within the bowel. It has a high resistance to gastric acid and shares similar functions as B. bifidum.
Bifidobacterium breve
B. breve is another branched, rod-shaped bacterium. The job of B. breve in the bowel is to ferment sugars and produce lactic acid as well as acetic acid. B. breve is a champion among probiotic bacteria due to its superior ability to metabolize many types of food.
Bifidobacterium infantis
B. infantis is a probiotic bacterium that inhabits the intestine of both infants and adults. According to a study sponsored by P&G Health Sciences Institute and published in the American Journal of Gastroenterology, B. infantis may be beneficial for bowel health. B. infantis plays an important role in basic digestion, proper metabolism and overall well-being.
Isotonix Digestive Enzyme Powder Drink:
Amylase
Amylases are enzymes that catalyze the hydrolysis of alpha-1, 4-glycosidic linkages of polysaccharides to yield dextrins, oligosaccharides, maltose and D-glucose. Amylases are derived from animal, fungal and plant sources.There are a few different amylases. These enzymes are classified according to the manner in which the glysosidic bond is attacked. Alpha-amylases hydrolyze alpha-1, 4-glycosidic linkages, randomly yielding dextrins, oligosaccharides and monosaccharides. Alpha-amylases are endo-amylases. Exoamylases hydrolyze the alpha-1, 4-glycosidic linkage only from the non-reducing outer polysaccharide chain ends. Exoamylases include beta-amylases and glucoamylases (gamma-amylases, amyloglucosidases). Beta-amylases yield beta-limit dextrins and maltose. Gamma-amylases yield glucose. Amylases are used as digestants. Amylase activity is expressed as Dextrinizing Units or DU.
Protease
Proteases are enzymes that break peptide bonds between amino acids in proteins. The process is called proteolytic cleavage, a common mechanism of activation or inactivation of enzymes especially involved in blood coagulation or digestion.
Proteases occur naturally in all organisms.
Lactase
Lactase are enzymes involved in the hydrolysis of the disaccharide lactose into constituent galactose and glucose monomers. In humans, lactase is present predominantly along the brush border membrane of the differentiated enterocytes lining the villi of the small intestine.
Lactase is essential for digestive hydrolysis of lactose in milk. Deficiency of the enzyme causes lactose intolerance; many humans become lactose intolerant as adults.
Lipase
A lipase is an enzyme that catalyzes the hydrolysis of ester bonds in lipid substrates. Most lipases act at a specific position on the glycerol backbone of a lipid substrate (A1, A2 or A3). Lipases are ubiquitous throughout living organisms, and genes encoding lipases are even present in certain viruses. Lipases, help in the metabolism, absorption and transport of lipids throughout the body. As biological membranes are integral to living cells and are largely composed of phospholipids, lipases play important roles in cell biology.
Cellulase
Cellulase is an enzyme complex which breaks down cellulose to beta-glucose. Aside from herbivores, most animals (including humans) do not produce cellulase in their bodies and are, therefore, unable to use much of the energy contained in plant material.
Cellulose is an indigestible plant polysaccharide. It is the principal constituent of the cell wall of plants. Cellulase has cellulolytic activity, meaning that it hydrolyzes cellulose... Cellulase is used as a digestive aid for the management of flatulence. The activity of cellulase is expressed in cellulose units or CU.
Sucrase
Sucrase is the enzyme involved in the hydrolysis of sucrose to fructose and glucose. It is secreted by the tips of the villi of the epithilum in the small intestines. Its levels are reduced in response to villi blunting events such as ciliac sprue. Sucrase increases during pregnancy and lactation as villi hypertrophy.
Bacillus Coagulans (Lactosporeä)*
Bacillus Coagulans is a lactic acid bacillus preparation manufactured and distributed by the Sabinsa Corporation. Fermented milks have been a part of the human diet since ancient times. Their efficacy in alleviating gastrointestinal disorders has been exploited in systems of traditional medicine the world over. Lactic acid bacteria, the indigenous microbial flora in fermented milks and natural inhabitants of the human gastrointestinal tract were thought to be responsible for the longevity of their hosts through their curative and prophylactic actions.
The role of lactic acid bacteria in gastrointestinal microecology has been the subject of extensive research. It is widely believed that these bacteria prevent the growth of putrefactive microorganisms responsible for ill health by competitive inhibition, the generation of a non-conducive acidic environment and/or by the production of bacteriocins. Their metabolites may include B group vitamins.
* Lactospore™ is a trademark of Sabinsa Corporation.
FAQ
Is Digestive Health Kit Safe?
Science
Ultimate Aloe Juice:
- Andersen D., et al. In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Res. 16(2):185-96, 1991.
- Ashleye, A.D. Applying heat during processing of the commercial Aloe Vera gel. Erde International 1, 40-44, 1983.
- Bautista-Perez R., et alI. In vitro antibradykinin activity of Aloe barbadensis gel. . J Ethnopharmacol. 93:89-92, 2004.
- Blitz, J. J., et al. Aloe Vera gel in peptic ulcer therapy: Preliminary report. J Am Osteopathol Soc. 62:731-735, 1963.
- Boudreau M., et al. An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe Vera. J Environ Sci Health C . 24:103-54, 2006.
- Cole, H.N. and Cole, K.K., Aloe Vera in Oriental Dermatology. Arch. Dermat. And Sympt, Vol. 47, PP. 250, 1943.
- Davis, R. H., et al. Wound healing. Oral and topical activity of Aloe Vera. J Am Podiatr Med Assoc. 79(11):559-562, 1989.
- Eamlamnam K., et al. Effects of Aloe Vera and sucralfate on gastric microcirculatory changes, cytokine levels and gastric ulcer healing in rats. World J Gastroenterol. 12(13):2034-9, 2006.
- Gjerstad, G and Riner, T.D. Current Status of Aloe as a Cure-All. Am. J. of Pharm, 140 (2): 58-64, 1968.
- Gjerstad, G. An appraisal of the Aloe Vera juice; College of Pharmacy, University of Texas, Austin. Vol. 84: pps. 43-46, 1969.
- Korkina, L., et al. The protective and healing effects of a natural antioxidant formulation based on ubiquinol and Aloe Vera against dextran sulfate- induced ulcerative colitis in rats. Biofactors. 18(1-4):255-264, 2003.
- Langmead L, et al. Randomized, double-blind, placebo-controlled trial of oral aloe Vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 19(7):739-47, 2004.
- Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 1;23(3):341-9, 2006.
- Langmead L., et al. Anti-inflammatory effects of aloe Vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 19(5):521-7, 2004.
- Robinson M. Medical therapy of inflammatory bowel disease for the 21st century. European Journal of Surgery. Supplement: 582: 90-8, 1998.
- Zhang X., et al. Isolation, structure elucidation, antioxidative and immunomodulatory properties of two novel dihydrocoumarins from Aloe Vera. Bioorg Med Chem Let
NutriClean Probiotics:
- Bonifait, L., et al. Probiotics for oral health: myth or reality? Journal of the Canadian Dental Association. 75(8): 585-590, 2009.
- Broekaert, I. and Walker, A. Probiotics and Chronic Disease. Journal of Clinical Gastroenterology. 40(3): 270-274, 2006.
- Brudnak, M. Probiotics as an adjuvant to detoxification protocols. Medical Hypotheses. 58(5): 382-385, 2002.
- Douglas, L. and Sanders, M. Probiotics and prebiotics in dietetics practice. Journal of the American Dietetic Association. 108(3): 510-521, 2008.
- Dugas, B., et al. Immunity and probiotics. Immunology Today. 20(9): 387-390, 1999.
- Erickson, K. and Hubbard, N. Probiotic immunomodulation in health and disease. Journal of Nutrition. 130(2S Suppl): 403S-409S, 2000.
- Fernandes, C., et al. Control of diarrhea by lactobacilli. Journal of Applied Nutrition. 40: 32-43, 1988.
- Friedrich, M. A bit of culture for children: probiotics may improve health and fight disease. Journal of the American Medical Association. 284(11): 1365-1366, 2000.
- Frohmader, T., et al. Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. American Journal of Critical Care. 19: 1-11, 2010.
- Gill, H. and Guarner, F. Probiotics and human health: a clinical perspective. Postgraduate Medical Journal. 80(947): 516-526, 2004.
- Guarner, F. and Malagelada, J. Gut flora in health and disease. Lancet. 361(9356): 512-519, 2003.
- Hatakka, K., et al. Probiotics reduce the prevalence of oral candida in the elderly – A randomized controlled trial. Journal of Dental Research. 86(2): 125-130, 2007.
- Hickson, M., et al. Use of probiotic Lactobacillus preparation to prevent diarrhea associated with antibiotics: randomised double blind placebo controlled trial. British Medical Journal. 335: 80-83, 2007.
- Isolauri, E., et al. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut. 50: 54-59, 2002.
- Ljungh, Å., et al. Isolation, selection and characteristics of Lactobacillus paracasei subsp. paracasei F19. Microbial Ecology in Health and Disease. 3: 4-6, 2002.
- Marteau, P., et al. Protection from gastrointestinal diseases with the use of probiotics. American Journal of Clinical Nutrition. 73(Suppl): 430S-436S, 2001.
- Parracho, H., et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. Journal of Medical Microbiology. 54: 987-991, 2005.
- Rastall, R. et al. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: An overview of enabling science and potential applications. FEMS Microbiology Ecology. 52: 145-152, 2005.
- Roberfroid, M. Prebiotics and probiotics: are they functional foods? American Journal of Clinical Nutrition. 71(Suppl): 1682S-1687S, 2000.
- Rolfe, R. The role of probiotic cultures in the control of gastrointestinal health. Journal of Nutrition. 130: 396S-402S, 2000.
- Shimauchi, H., et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. Journal of Clinical Peridontology. 35: 897-905, 2008.
- Szajewska, H. and Mrukowicz, J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. Journal of Pediatric Gastroenterology and Nutrition. 33: S17-S25, 2001.
- Tuohy, K., et al. Using probiotics and prebiotics to improve gut health. Therapeutic Focus. 8(15): 692-700, 2003.
- Van Niel, W., et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 109(4): 678-683, 2002.
- Verdenelli, M., et al. Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human feces. European Journal of Nutrition. 48: 355-363, 2009.
- Wullt, M., et al. Lactobacillus plantarum 299v enhances the concentrations of fecal short chain fatty acids in patients with recurrent Clostridum difficile-associated diarrhea. Digestive Diseases and Sciences. 52: 2082-2086, 2007.
Isotonix Digestive Enzyme Powder Drink:
- Afonso, C. L., E. R. Tulman, Z. Lu, E. Oma, G. F. Kutish, and D. L. Rock. 1999. The genome of Melanoplus sanguinipes entomopoxvirus. J Virol 73:533-52.
- Anthony H, Collins CE, Davidson G, et al. Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines. J Pediatr—Child Health. 1999; 35:125-129.
- Barrett A.J., Rawlings ND, Woessner JF. The Handbook of Proteolytic Enzymes, 2nd ed. Academic Press, 2003. ISBN 0120796104.
- Billigmann P. [Enzyme therapy—an alternative in treatment of herpes zoster. A controlled study of 192 patients]. [Article in German]. Fortschr Med. 1995; 113:43-48.
- Bock U, Kolac C, Borchard G, et al. Transport of proteolytic enzymes across Caco-2 cell monolayers. Pharm Res. 1998; 15:1393-1400.
- Brady, L., A. M. Brzozowski, Z. S. Derewenda, E. Dodson, G. Dodson, S. Tolley, J. P. Turkenburg, L. Christiansen, B. Huge-Jensen, L. Norskov, and et al. 1990. A serine protease triad forms the catalytic centre of a triacylglycerol lipase. Nature 343:767-70.
- Carriere, F., C. Withers-Martinez, H. van Tilbeurgh, A. Roussel, C. Cambillau, and R. Verger. 1998. Structural basis for the substrate selectivity of pancreatic lipases and some related proteins. Biochim Biophys Acta 1376:417-32.
- Chapin III, F.S., P.A. Matson, H.A. Mooney. Principles of Terrestrial Ecosystem Ecology. Springer-Verlag New York, NY. 2002
- Coenen TMM, Bertens AMC, De Hoog SCM, Verspeek-Rip CM. Safety evaluation of a lactase enzyme preparation derived from Kluyveromyces lactis. Food Chem Toxicol. 2000; 38:671-677.
- de Smet PA, Pegt GW, Meyboom RH. [Acute circulatory shock following administration of the non-regular enzyme preparation Wobe-Mugos]. [Article in Dutch]. Ned Tijdschr Geneeskd. 1991; 135:2341-2344.
- Diaz, B. L., and J. P. Arm. 2003. Phospholipase A(2). Prostaglandins Leukot Essent Fatty Acids 69:87-97.
- Dominguez-Munoz JE, Birckelbach U, Glassbrenner B, et al. Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: comparison between two enzyme preparations. Aliment Pharmacol Ther. 1997; 11:403-408.
- Eckert K, Grabowska E, Stange R, et al. Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients. Oncol Rep. 1999; 6:1191-1199.
- Egmond, M. R., and C. J. van Bemmel. 1997. Impact of Structural Information on Understanding of Lipolytic Function, p. 119-129, Methods Enzymol vol. 284.
- Farkas G, Takacs T, Baradnay G, Szasz Z. [Effect of pancreatin replacement on pancreatic function in the postoperative period after pancreatic surgery]. [Article in Hungarian]. Orv Hetil. 1999; 140:2751-2754.
- Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P. 2001. Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6. Ann Genet 44(1):25-32.
- Girod, A., C. E. Wobus, Z. Zadori, M. Ried, K. Leike, P. Tijssen, J. A. Kleinschmidt, and M. Hallek. 2002. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J Gen Virol 83:973-8.
- Goni FM, Alonso A. 2002 Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 531(1):38-46.
- Greenberger NJ. Enzymatic therapy in patients with chronic pancreatitis. Gastrenterol Clin North Am. 1999; 28:687-693.
- Hedstrom L. Serine Protease Mechanism and Specificity. Chem Rev 2002;102:4501-4523.
- Heikinheimo, P., A. Goldman, C. Jeffries, and D. L. Ollis. 1999. Of barn owls and bankers: a lush variety of alpha/beta hydrolases. Structure Fold Des 7:R141-6.
- Hooper NM. Proteases in Biology and Medicine. London: Portland Press, 2002. ISBN 1855781476.
- Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002;30: 233-7. Free text. PMID 11788828.
- Kaul R, Mishra BK, Sutrador P, et al. The role of Wobe-Mugos in reducing acute sequelae of radiation in head and neck cancers—a clinical phase-III randomized trial. Indian J Cancer. 1999; 36:141-148.
- Kiessling WR. [Anaphylactic reaction in enzyme therapy of multiple sclerosis]. [Article in German]. Fortschr Neurol Psychiatr. 1987; 55:385-386.
- Klein G, Kullich W. [Reducing pain by oral enzyme therapy in rheumatic diseases]. [Article in German]. Wien Med Wochenschr. 1999; 149:577-580.
- Lowe, M. E. 1992. The catalytic site residues and interfacial binding of human pancreatic lipase. J Biol Chem 267:17069-73.
- Olds LC, Sibley E. Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis regulatory element. Hum Mol Genet 2003 Sep 15; 12(18): 2333-40. Free text. PMID 12915462.
- Puente XS, Lopez-Otin C. A Genomic Analysis of Rat Proteases and Protease Inhibitors. Genome Biol 2004;14:609-622.
- Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and Mouse Proteases: a Comparative Genomic Approach. Nat Rev Genet 2003;4:544-558.
- Retrieved from " http://www.lactospore.com/intro.htm"
- Retrieved from "http://en.wikipedia.org/wiki/Lactase"
- Retrieved from "http://en.wikipedia.org/wiki/Lipase"
- Retrieved from "http://en.wikipedia.org/wiki/Sucrase"
- Ross J, Jiang H, Kanost MR, Wang Y. Serine proteases and their homologs in the Drosophila melanogaster genome: an initial analysis of sequence conservation and phylogenetic relationships. Gene 2003;304:117-31.
- Rowan AD, Buttle DJ, Barrett AJ. The cysteine proteinases of the pineapple plant. Biochem J. 1990; 266:869-875.
- Schrag, J. D., and M. Cygler. 1997. Lipases and alpha/beta hydrolase fold. Methods Enzymol 284:85-107.
- Seyis I, Aksoz N. Production of lactase by Trichoderma sp.. Food Technol Biotechnol 2004;42:121–124. Free text.
- Solomon, Eldra P.; Berg, Linda R.; & Martin, Diana W. (2002). Biology (6th ed). Thovertical-align: baseline;">Southan C. A genomic perspective on human proteases as drug targets. Drug Discov Today 2001;6:681-688.
- Spiegel, S., D. Foster, and R. Kolesnick. 1996. Signal transduction through lipid second messengers. Curr Opin Cell Biol 8:159-67.
- Stauder G, Ransberger K, Streichhan P, et al. The use of hydrolytic enzymes as adjuvant therapy in AIDS/ARC/LAS patients. Biomed Pharmacother. 1988; 42:31-34.
- Steffen C, Menzel J. [Enzyme breakdown of immune complexes]. [Article in German]. Z Rheumatol. 1983; 42:249-255.
- Steffen C, Smolen J, Miehlke K, et al. [Enzyme therapy in comparison with immune complex determinations in chronic polyarthritis]. [Article in German]. Z Rheumatol. 1985; 44:51-56.
- Svendsen, A. 2000. Lipase protein engineering. Biochim Biophys Acta 1543:223-238.
- The Merck Manual of Diagnosis and Therapy, Chapter 24
- Tjoelker, L. W., C. Eberhardt, J. Unger, H. L. Trong, G. A. Zimmerman, T. M. McIntyre, D. M. Stafforini, S. M. Prescott, and P. W. Gray. 1995. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem 270:25481-7.
- Wald M, Olejár T, Pouková P, Zadinova M. Proteinases reduce metastatic dissemination and increase survival time in C57B16 mice with the Lewis lung carcinoma. Life Sciences. 1998; 63:PL237-243.
- Wald M, Závadová E, Pouková P, et al. Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice. Life Sciences. 1998; 62:PL43-48.
- Winkler, F. K., A. D'Arcy, and W. Hunziker. 1990. Structure of human pancreatic lipase. Nature 343:771-4.
- Withers-Martinez, C., F. Carriere, R. Verger, D. Bourgeois, and C. Cambillau. 1996. A pancreatic lipase with a phospholipase A1 activity: crystal structure of a chimeric pancreatic lipase-related protein 2 from guinea pig. Structure 4:1363-74.
- Wolf M, Ransberger K. [Effect of proteolytic enzymes on the reciprocal growth modification of normal and tumor tissues]. [Article in German]. Arch Geschwultstforsch. 1968; 31:317-331.
Reviews
Customer Rating
4.7 out of 5 star rating.
(6 reviews)
would recommend this product.
- Newest
- Highest Rating
- Lowest Rating
- Oldest
- Most Helpful
用左兩個月腸胃改善左好多
消化保健組合
by Anonymous
on 6/6/2019
此產品幫到我腸胃更健康,舒服,我和我的客人都喜歡此產品。
肠道健康一定要用它
by GUAN
on 10/5/2019
非常好的肠道健康产品,帮你肠道洗澡,排毒👍👍
促進腸道健康
by Chan
Shop Consultant
on 5/2/2019
農曆新年期間雖然大吃大喝,但這套消化保健組合幫助我的腸胃快速消化食物及維持排便規律。
改善咗長期便秘嘅問題
by Pong
on 15/1/2019
這產品幫助到我 舒緩到暗瘡問題及便秘問題。
特別便秘問題 幾天已經見到效果。
Share this page!
Copy this link and paste to your favorite social, blog or website.
Link copied! Please paste and share on your favorite platforms.
There was an error copying to your clipboard. Please try again later.